Rheumatic Complications of Immune Checkpoint Inhibitors

被引：3

作者：

Ghosh, Nilasha ^{[1
]}

Bass, Anne R. ^{[1
]}

机构：

[1] Weill Cornell Med, Hosp Special Surg, New York, NY USA

来源：

RHEUMATIC DISEASE CLINICS OF NORTH AMERICA | 2022年 / 48卷 / 02期

基金：

美国国家卫生研究院;

关键词：

Immune-related adverse events; Immune checkpoint inhibitors; Cancer; Rheumatoid arthritis; Polymyalgia rheumatica; Myositis; Disease-modifying antirheumatic drugs; ADVERSE EVENTS; CANCER; NIVOLUMAB; IMMUNOTHERAPY; ASSOCIATION; MONOTHERAPY; IPILIMUMAB; MANAGEMENT; DISORDERS; OUTCOMES;

D O I：

10.1016/j.rdc.2022.02.002

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：411 / 428

页数：18

共 58 条

[1] Use of Immune Checkpoint Inhibitors in the Treatment of Patients With Cancer and Preexisting Autoimmune Disease A Systematic Review [J].

Abdel-Wahab, Noha ;

Shah, Mohsin ;

Lopez-Olivo, Maria A. ;

Suarez-Almazor, Maria E. .

ANNALS OF INTERNAL MEDICINE, 2018, 168 (02) :121-+

[2] Early introduction of selective immunosuppressive therapy associated with favorable clinical outcomes in patients with immune checkpoint inhibitor-induced colitis [J].

Abu-Sbeih, Hamzah ;

Ali, Faisal S. ;

Wang, Xuemei ;

Mallepally, Niharika ;

Chen, Ellie ;

Altan, Mehmet ;

Bresalier, Robert S. ;

Charabaty, Aline ;

Dadu, Ramona ;

Jazaeri, Amir ;

Lashner, Bret ;

Wang, Yinghong .

JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7

[3]

[Anonymous], 2017, Common terminology criteria for adverse events (CTCAE)

[4] A systematic review of adverse events in randomized trials assessing immune checkpoint inhibitors [J].

Arnaud-Coffin, Patrick ;

Maillet, Denis ;

Gan, Hui K. ;

Stelmes, Jean-Jacques ;

You, Benoit ;

Dalle, Stephane ;

Peron, Julien .

INTERNATIONAL JOURNAL OF CANCER, 2019, 145 (03) :639-648

[5] Immune Checkpoint Inhibitor-Associated Polymyalgia Rheumatica/Giant Cell Arteritis Occurring in a Patient After Treatment With Nivolumab [J].

Betrains, Albrecht Edward ;

Blockmans, Daniel Engelbert .

JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2021, 27 (8S) :S555-S556

[6] Immune checkpoint inhibitor-induced inflammatory arthritis persists after immunotherapy cessation [J].

Braaten, Tawnie J. ;

Brahmer, Julie R. ;

Forde, Patrick M. ;

Le, Dung ;

Lipson, Evan J. ;

Naidoo, Jarushka ;

Schollenberger, Megan ;

Zheng, Lei ;

Bingham, Clifton O., III ;

Shah, Ami A. ;

Cappelli, Laura C. .

ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 (03) :332-338

[7] Polymyalgia rheumatica-like syndrome from checkpoint inhibitor therapy: case series and systematic review of the literature [J].

Calabrese, Cassandra ;

Cappelli, Laura C. ;

Kostine, Marie ;

Kirchner, Elizabeth ;

Braaten, Tawnie ;

Calabrese, Leonard .

RMD OPEN, 2019, 5 (01)

[8] Association of HLA-DRB1 shared epitope alleles and immune checkpoint inhibitor-induced inflammatory arthritis [J].

Cappelli, Laura C. ;

Dorak, Mehmet T. ;

Bettinotti, Maria P. ;

Bingham, Clifton O., III ;

Shah, Ami A. .

RHEUMATOLOGY, 2019, 58 (03) :476-480

[9] Clinical presentation of immune checkpoint inhibitor-induced inflammatory arthritis differs by immunotherapy regimen [J].

Cappelli, Laura C. ;

Brahmer, Julie R. ;

Forde, Patrick M. ;

Le, Dung T. ;

Lipson, Evan J. ;

Naidoo, Jarushka ;

Zheng, Lei ;

Bingham, Clifton O., III ;

Shah, Ami A. .

SEMINARS IN ARTHRITIS AND RHEUMATISM, 2018, 48 (03) :553-557

[10] Rheumatic and Musculoskeletal Immune-Related Adverse Events Due to Immune Checkpoint Inhibitors: A Systematic Review of the Literature [J].

Cappelli, Laura C. ;

Gutierrez, Anna Kristina ;

Bingham, Clifton O., III ;

Shah, Ami A. .

ARTHRITIS CARE & RESEARCH, 2017, 69 (11) :1751-1763

← 1 2 3 4 5 6 →